Alanongy IV infusion 250mg, manufactured by Sand Pharma, contains Nelarabine, with YJ code 4229402A1028 and a standard of 250mg 50mL 1 bottle. Nelarabine is an antineoplastic agent used for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in patients who have not responded to or have relapsed after prior therapies.
Alanongy IV infusion 250mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).